Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations
published in: The New England Journal of Medicine
date of publication: 2020-07-01
main subject: ibrutinib, chronic lymphocytic leukemia
Cites articles
There is nothing here
Article - wd:Q98162165